Developer docs
API playgroundTry for free, no card

Search company profiles

RiverGlade Capital

Full company profile

uuid00028ax

Namestring
RiverGlade Capital
Legal namestring
RiverGlade Capital
Company typeenum
Private
Founded yearint
2017
Descriptiontext

RiverGlade Capital is a Chicago-based, healthcare-focused private equity firm founded in 2017 that invests exclusively in lower middle market healthcare services companies. The firm targets companies that are "driving efficiencies, improving performance, and lowering costs across the healthcare ecosystem" and positions itself as a collaborative, founder-aligned partner for growth capital, investment, or sale transactions. Its disclosed portfolio spans pediatric dentistry (Kids Care Dental, 2019), medical solutions (Longhorn Health Solutions, 2020), in-home care (Home Helpers, 2021), and home health and hospice (James River Home Health), reflecting a deliberate vertical build-out across fragmented, non-hospital healthcare sub-sectors.

The firm's go-to-market is relationship-driven, relying on direct outreach to founders, management teams, and healthcare M&A intermediaries rather than broad marketing. Its buy-and-build approach is evidenced by add-on acquisitions such as James River Home Health's March 2026 acquisition of Golden Rule Hospice, which extended that platform from Central Virginia into metro Atlanta. RiverGlade's revenue mechanics follow the standard private equity model — management fees on committed capital plus carried interest on investment realizations — with terms negotiated individually with limited partners and portfolio companies; neither fees, fund size, nor AUM are publicly disclosed.

The team is small and specialized: founders and managing partners Daniel W. Rosenberg and Garrick Rice, plus principals Dan Skowronski and Natalie Linsalata, with total headcount in the 11-50 range. Ownership structure, institutional LPs, fund vintage, and management equity are not disclosed in available source material, representing a notable data gap for any prospective co-investor or secondary participant.

Short descriptiontext

RiverGlade Capital is a Chicago-based, healthcare-focused private equity firm founded in 2017 that invests in lower middle market healthcare services companies. It provides growth capital and operational support to founder-led platforms across home health, dental, and medical solutions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersChicago, United States
HQ citystring
Chicago
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare private equity, lower middle market investing, growth capital, healthcare buyouts, value creation
Industry1 code
PRIMARYFSANACAD
Business Services (B2B) Growth Equity
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Portfolio Management and Investment Advice52394
SIC code1 code
  • Investment Advice6282
Product category
Healthcare Private Equity
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Carried Interest and Management Fees
TypeManaged Services
Description

As a private equity firm, RiverGlade Capital generates revenue through carried interest (performance fees on investment returns) and management fees on committed capital. This is standard for healthcare-focused PE funds targeting the lower middle market.

riverglade.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

RiverGlade Capital is a healthcare-focused private equity firm that invests in lower middle market healthcare companies. The firm provides equity capital, strategic guidance, and operational support to portfolio companies, typically through control-oriented growth investments and buyout transactions in the healthcare sector. Its offering is centered on long-duration fund-based investing rather than discrete productized services.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

RiverGlade Capital is a healthcare-focused private equity firm that invests in lower middle market companies driving efficiencies, improving performance, and lowering costs across the healthcare ecosystem. The firm provides capital investment and operational expertise to healthcare companies seeking accelerated growth, serving as a trusted partner for founders exploring investment, sale, or expansion opportunities. As a private equity firm, RiverGlade Capital does not offer a software product or platform but rather provides investment and growth support to its portfolio companies.

Product and service2 records
1Healthcare Private Equity Investment Capital
CategoryPrivate Equity Fund Investment
Description

Equity capital invested in lower middle market healthcare companies through control-oriented growth and buyout transactions, typically in partnership with founders, owners, and management teams.

2Portfolio Company Operational and Strategic Support
CategoryInvestment Value-Add Services
Description

Hands-on operational support, strategic guidance, and value creation services provided to healthcare portfolio companies post-investment, leveraging the firm's healthcare sector relationships and operating expertise.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RiverGlade Capital

Healthcare Private Equityrivergladecapital.com

RiverGlade Capital is a Chicago-based, healthcare-focused private equity firm founded in 2017 that invests in lower middle market healthcare services companies. It provides growth capital and operational support to founder-led platforms across home health, dental, and medical solutions.

What RiverGlade Capital does

RiverGlade Capital is a Chicago-based, healthcare-focused private equity firm founded in 2017 that invests exclusively in lower middle market healthcare services companies. The firm targets companies that are "driving efficiencies, improving performance, and lowering costs across the healthcare ecosystem" and positions itself as a collaborative, founder-aligned partner for growth capital, investment, or sale transactions. Its disclosed portfolio spans pediatric dentistry (Kids Care Dental, 2019), medical solutions (Longhorn Health Solutions, 2020), in-home care (Home Helpers, 2021), and home health and hospice (James River Home Health), reflecting a deliberate vertical build-out across fragmented, non-hospital healthcare sub-sectors.

The firm's go-to-market is relationship-driven, relying on direct outreach to founders, management teams, and healthcare M&A intermediaries rather than broad marketing. Its buy-and-build approach is evidenced by add-on acquisitions such as James River Home Health's March 2026 acquisition of Golden Rule Hospice, which extended that platform from Central Virginia into metro Atlanta. RiverGlade's revenue mechanics follow the standard private equity model — management fees on committed capital plus carried interest on investment realizations — with terms negotiated individually with limited partners and portfolio companies; neither fees, fund size, nor AUM are publicly disclosed.

The team is small and specialized: founders and managing partners Daniel W. Rosenberg and Garrick Rice, plus principals Dan Skowronski and Natalie Linsalata, with total headcount in the 11-50 range. Ownership structure, institutional LPs, fund vintage, and management equity are not disclosed in available source material, representing a notable data gap for any prospective co-investor or secondary participant.

RiverGlade Capital firmographics

Firmographics
Name
RiverGlade Capital
Legal name
RiverGlade Capital
Website
https://rivergladecapital.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
RiverGlade Capital is a Chicago-based, healthcare-focused private equity firm founded in 2017 that invests in lower middle market healthcare services companies. It provides growth capital and operational support to founder-led platforms across home health, dental, and medical solutions.
Ownership category
akta.pro rank

RiverGlade Capital industry classification

Industry
Product category
Healthcare Private Equity
NAICS
Portfolio Management and Investment Advice (523940), Portfolio Management and Investment Advice (52394)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANACAD
Business Services (B2B) Growth Equity

Keywords

  • Healthcare private equity
  • Lower middle market investing
  • Growth capital
  • Healthcare buyouts
  • Value creation

Where RiverGlade Capital is headquartered

Location

Headquarters

HQ city
Chicago
HQ country
United States
HQ region
North America

Offices1 record

Markets served

RiverGlade Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Carried Interest and Management Fees: As a private equity firm, RiverGlade Capital generates revenue through carried interest (performance fees on investment returns) and management fees on committed capital. This is standard for healthcare-focused PE funds targeting the lower middle market.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

RiverGlade Capital product offering

Product offering

Core offering

RiverGlade Capital is a healthcare-focused private equity firm that invests in lower middle market healthcare companies. The firm provides equity capital, strategic guidance, and operational support to portfolio companies, typically through control-oriented growth investments and buyout transactions in the healthcare sector. Its offering is centered on long-duration fund-based investing rather than discrete productized services.

Product overview

RiverGlade Capital is a healthcare-focused private equity firm that invests in lower middle market companies driving efficiencies, improving performance, and lowering costs across the healthcare ecosystem. The firm provides capital investment and operational expertise to healthcare companies seeking accelerated growth, serving as a trusted partner for founders exploring investment, sale, or expansion opportunities. As a private equity firm, RiverGlade Capital does not offer a software product or platform but rather provides investment and growth support to its portfolio companies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Healthcare Private Equity Investment Capital Equity capital invested in lower middle market healthcare companies through control-oriented growth and buyout transactions, typically in partnership with founders, owners, and management teams.
  • Portfolio Company Operational and Strategic Support Hands-on operational support, strategic guidance, and value creation services provided to healthcare portfolio companies post-investment, leveraging the firm's healthcare sector relationships and operating expertise.

Companies that use RiverGlade Capital

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

RiverGlade Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

RiverGlade Capital partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

RiverGlade Capital competitors and assessment

Company assessment

Market position

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

RiverGlade Capital social profiles

Digital presence

RiverGlade Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RiverGlade Capital leadership team

Management profile

Number of profiles

Profiles4 records

RiverGlade Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RiverGlade Capital M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RiverGlade Capital

What does RiverGlade Capital do?

RiverGlade Capital is a healthcare-focused private equity firm that invests in lower middle market healthcare companies. The firm provides equity capital, strategic guidance, and operational support to portfolio companies, typically through control-oriented growth investments and buyout transactions in the healthcare sector. Its offering is centered on long-duration fund-based investing rather than discrete productized services.

Is RiverGlade Capital a public or private company?

RiverGlade Capital is a private company. It is classified as management employee owned and is currently operating.

When was RiverGlade Capital founded?

RiverGlade Capital was founded in 2017. It employs 11 to 50 people.

Where is RiverGlade Capital based?

RiverGlade Capital is headquartered in Chicago, United States, in the North America region.

How does RiverGlade Capital make money?

One revenue line is on record: carried Interest and Management Fees.

Does RiverGlade Capital have an API?

No public API is recorded for RiverGlade Capital.

What industry is RiverGlade Capital in?

RiverGlade Capital's product category is Healthcare Private Equity. Its primary akta.pro industry code is FSANACAD, Business Services (B2B) Growth Equity. Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PrwebRiverGlade Capital Partners with Veteran Franchising Executive Brian Petranick to Form Sentinel Care GroupRiverGlade Capital partnered with Brian Petranick to form Sentinel Care Group, a new platform to build a leading franchise brand. Petranick brings nearly 30 years of franchising experience, including 22 years at Right at Home. Sentinel will pursue acquisitions or partnerships and may launch de novo franchise systems.PR Newswire2nd Chance Welcomes New CEO Brandon Dale2nd Chance Treatment Centers, a regional outpatient behavioral health network based in Phoenix, Arizona, appointed Brandon Dale as President and Chief Executive Officer effective February 2, 2022. Dale brings more than 25 years of healthcare sector experience, most recently serving as Chief Commercial Officer at Hanger, Inc., where he spent over two decades in various leadership roles. RiverGlade Capital, a healthcare-focused private equity firm, partnered with 2nd Chance in early 2021 and had Operating Partner Jim Hudak serving as interim CEO until this appointment.PR NewswireRiverGlade Capital Announces Sale of U.S. Oral Surgery ManagementRiverGlade Capital sold its controlling stake in U.S. Oral Surgery Management to Oak Hill Capital. The deal involves USOSM, which operates 48 oral surgery practices and 141 surgeons across 18 states. Moelis & Company provided M&A advisory and Kirkland & Ellis provided legal counsel.PR NewswireDIT Announces New Executive Team to Pursue National Platform for Vascular AccessDynamic Infusion Therapy, LLC (DIT) announced a new executive team assembled to fuel growth and expand its national platform for outsourced vascular access services. RiverGlade Capital, a healthcare-focused private equity firm, partnered with DIT earlier this year to build on the company's clinical model and reputation as the nation's largest outsourced provider of vascular access insertions. The new leadership team includes Peter Harris as President & CEO, Tim Boes as Chief Development Officer, and Thomas Bumpass as CFO, with plans to expand services to additional hospitals and healthcare facilities across the country.PR NewswireRiverGlade Capital Announces Three Investments in First Half of 2021RiverGlade Capital announced partnerships with Dynamic Infusion Therapy, Home Helpers Home Care, and 2nd Chance Treatment Centers in the first half of 2021. The investments target outsourced vascular services, home care, and behavioral treatment, with DIT serving over 700 health systems and 2nd Chance treating more than 7,000 patients.PR NewswireHome Helpers® Home Care Acquired by RiverGlade CapitalH.H. Franchising Systems Inc., the operator of Home Helpers® Home Care, has been acquired by RiverGlade Capital, a Chicago-based private equity firm specializing in healthcare investments. The transaction marks a change from previous ownership by Linsalata Capital Partners, with the company retaining its leadership team and Cincinnati headquarters to accelerate growth across its 41-state network.RivergladeRiverGlade Capital Announces the Formation of U.S. Oral Surgery ManagementRiverGlade Capital announced the formation of U.S. Oral Surgery Management (USOSM), a management services company for the oral surgery sector headquartered outside Dallas, Texas. The entity operates as the largest network of oral surgery practices in the country, partnering with surgeons across 27 clinic locations in Texas. This structure leverages a physician-partnership model to provide operational and administrative support while preserving clinical autonomy.PrwebRiverGlade Capital Announces the Formation of U.S. Oral Surgery ManagementRiverGlade Capital formed U.S. Oral Surgery Management, a management services company for oral surgery practices. The company partners with surgeons across 27 clinic locations and is led by Rick Hall. It aims to scale quickly by partnering with high-reputation practices.FinSMEsPrivate Equity Firm RiverGlade Capital Adds Jim Hudak and Dan SkowronskiRiverGlade Capital appointed Jim Hudak as Operating Partner and Dan Skowronski as Vice President. Hudak brings healthcare industry experience from Paradigm Outcomes and UnitedHealth Group, while Skowronski has eight years in private equity investing.